Aurora kinase inhibitor VE 465 synergistically enhances cytotoxicity of carboplatin in ovarian cancer cells through induction of apoptosis and downregulation of histone 3

References

• Jemal A, Clegg LX, Ward E, Ries LA, Wu X, Jamison PM, et al. Annual report to the nation on the status of cancer, 1975-2001, with a special feature regarding survival. Cancer 2004; 101:3 - 27; http://dx.doi.org/10.1002/cncr.20288; PMID: 15221985
   PubMed Web of Science ®Google Scholar
• Kavanagh JJSS, Pecoreli S, Dipertrillo A, Einhorn N. Chemotherapy in advanced ovarian cancer. Cambrige, MA: Blackwell Scientific Publications, 1998.
   Google Scholar
• McGuire WP, Hoskins WJ, Brady MF, Kucera PR, Partridge EE, Look KY, et al. Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer. [see comments] N Engl J Med 1996; 334:1 - 6; http://dx.doi.org/10.1056/NEJM199601043340101; PMID: 7494563
   PubMed Web of Science ®Google Scholar
• Verschraegen CFDK, Johnes LA. Biology of gynecologic cancers. Cambrige, MA: Blackwell Scientific Publications, 1998.
   Google Scholar
• Kudelka AP, Verschraegen CF, Shen Y, Gonzalez De Leon C, Edwards CL, Freedman RS, et al. Long-term results and pharmacokinetics of high-dose paclitaxel in patients with refractory epithelial ovarian carcinoma. Int J Gynecol Cancer 1999; 9:44 - 53; http://dx.doi.org/10.1046/j.1525-1438.1999.09856.x; PMID: 11240742
   PubMed Web of Science ®Google Scholar
• Fu S, Hu W, Kavanagh JJ, Bast RC Jr.. Targeting Aurora kinases in ovarian cancer. Expert Opin Ther Targets 2006; 10:77 - 85; http://dx.doi.org/10.1517/14728222.10.1.77; PMID: 16441230
   PubMed Web of Science ®Google Scholar
• Sen S, Zhou H, White RA. A putative serine/threonine kinase encoding gene BTAK on chromosome 20q13 is amplified and overexpressed in human breast cancer cell lines. Oncogene 1997; 14:2195 - 200; http://dx.doi.org/10.1038/sj.onc.1201065; PMID: 9174055
   PubMed Web of Science ®Google Scholar
• Zhou H, Kuang J, Zhong L, Kuo WL, Gray JW, Sahin A, et al. Tumour amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformation. Nat Genet 1998; 20:189 - 93; http://dx.doi.org/10.1038/2496; PMID: 9771714
   PubMed Web of Science ®Google Scholar
• Sun C, Chan F, Briassouli P, Linardopoulos S. Aurora kinase inhibition downregulates NF-kappaB and sensitises tumour cells to chemotherapeutic agents. Biochem Biophys Res Commun 2007; 352:220 - 5; http://dx.doi.org/10.1016/j.bbrc.2006.11.004; PMID: 17113039
   PubMed Web of Science ®Google Scholar
• Sakakura C, Hagiwara A, Yasuoka R, Fujita Y, Nakanishi M, Masuda K, et al. Tumour-amplified kinase BTAK is amplified and overexpressed in gastric cancers with possible involvement in aneuploid formation.PG - 824-31. Br J Cancer 2001; 12:84
   Google Scholar
• Li D, Zhu J, Firozi PF, Abbruzzese JL, Evans DB, Cleary K, et al. Overexpression of oncogenic STK15/BTAK/Aurora A kinase in human pancreatic cancer. Clin Cancer Res 2003; 9:991 - 7; PMID: 12631597
   PubMed Web of Science ®Google Scholar
• Gritsko TM, Coppola D, Paciga JE, Yang L, Sun M, Shelley SA, et al. Activation and overexpression of centrosome kinase BTAK/Aurora-A in human ovarian cancer. Clin Cancer Res 2003; 9:1420 - 6; PMID: 12684414
   PubMed Web of Science ®Google Scholar
• Landen CN Jr., Lin YG, Immaneni A, Deavers MT, Merritt WM, Spannuth WA, et al. Overexpression of the centrosomal protein Aurora-A kinase is associated with poor prognosis in epithelial ovarian cancer patients. Clin Cancer Res 2007; 13:4098 - 104; http://dx.doi.org/10.1158/1078-0432.CCR-07-0431; PMID: 17634535
   PubMed Web of Science ®Google Scholar
• Wilkinson RW, Odedra R, Heaton SP, Wedge SR, Keen NJ, Crafter C, et al. AZD1152, a selective inhibitor of Aurora B kinase, inhibits human tumor xenograft growth by inducing apoptosis. Clin Cancer Res 2007; 13:3682 - 8; http://dx.doi.org/10.1158/1078-0432.CCR-06-2979; PMID: 17575233
   PubMed Web of Science ®Google Scholar
• Yang J, Ikezoe T, Nishioka C, Tasaka T, Taniguchi A, Kuwayama Y, et al. AZD1152, a novel and selective aurora B kinase inhibitor, induces growth arrest, apoptosis, and sensitization for tubulin depolymerizing agent or topoisomerase II inhibitor in human acute leukemia cells in vitro and in vivo. Blood 2007; 110:2034 - 40; http://dx.doi.org/10.1182/blood-2007-02-073700; PMID: 17495131
   PubMed Web of Science ®Google Scholar
• Lin YG, Immaneni A, Merritt WM, Mangala LS, Kim SW, Shahzad MM, et al. Targeting aurora kinase with MK-0457 inhibits ovarian cancer growth. Clin Cancer Res 2008; 14:5437 - 46; http://dx.doi.org/10.1158/1078-0432.CCR-07-4922; PMID: 18765535
   PubMed Web of Science ®Google Scholar
• Fancelli D, Berta D, Bindi S, Cameron A, Cappella P, Carpinelli P, et al. Potent and selective Aurora inhibitors identified by the expansion of a novel scaffold for protein kinase inhibition. J Med Chem 2005; 48:3080 - 4; http://dx.doi.org/10.1021/jm049076m; PMID: 15828847
   PubMed Web of Science ®Google Scholar
• Cheetham GM, Knegtel RM, Coll JT, Renwick SB, Swenson L, Weber P, et al. Crystal structure of aurora-2, an oncogenic serine/threonine kinase. J Biol Chem 2002; 277:42419 - 22; http://dx.doi.org/10.1074/jbc.C200426200; PMID: 12237287
   PubMed Web of Science ®Google Scholar
• Husain A, Chi DS, Prasad M, Abu-Rustum N, Barakat RR, Brown CL, et al. The role of laparoscopy in second-look evaluations for ovarian cancer. Gynecol Oncol 2001; 80:44 - 7; http://dx.doi.org/10.1006/gyno.2000.6036; PMID: 11136568
   PubMed Web of Science ®Google Scholar
• Modesitt SC, Ramirez P, Zu Z, Bodurka-Bevers D, Gershenson D, Wolf JK. In vitro and in vivo adenovirus-mediated p53 and p16 tumor suppressor therapy in ovarian cancer. Clin Cancer Res 2001; 7:1765 - 72; PMID: 11410518
   PubMed Web of Science ®Google Scholar
• Freedman RS, Pihl E, Kusyk C, Gallager HS, Rutledge F. Characterization of an ovarian carcinoma cell line. Cancer 1978; 42:2352 - 9; http://dx.doi.org/10.1002/1097-0142(197811)42:5<2352::AID-CNCR2820420536>3.0.CO;2-#; PMID: 719612
   PubMed Web of Science ®Google Scholar
• Thompson MA, Adelson MD, Kaufman LM. Lupron retards proliferation of ovarian epithelial tumor cells cultured in serum-free medium. J Clin Endocrinol Metab 1991; 72:1036 - 41; http://dx.doi.org/10.1210/jcem-72-5-1036; PMID: 1902482
   PubMed Web of Science ®Google Scholar
• Heise C, Lemmon M, Kirn D. Efficacy with a replication-selective adenovirus plus cisplatin-based chemotherapy: dependence on sequencing but not p53 functional status or route of administration. Clin Cancer Res 2000; 6:4908 - 14; PMID: 11156251
   PubMed Web of Science ®Google Scholar
• Mujoo K, Zhang L, Klostergaard J, Donato NJ. Emergence of cisplatin-resistant cells from the OVCAR-3 ovarian carcinoma cell line with p53 mutations, altered tumorigenicity, and increased apoptotic sensitivity to p53 gene replacement. Int J Gynecol Cancer 2000; 10:105 - 14; http://dx.doi.org/10.1046/j.1525-1438.2000.00018.x; PMID: 11240661
   PubMed Web of Science ®Google Scholar
• Auzenne E, Donato NJ, Li C, Leroux E, Price RE, Farquhar D, et al. Superior therapeutic profile of poly-L-glutamic acid-paclitaxel copolymer compared with taxol in xenogeneic compartmental models of human ovarian carcinoma. Clin Cancer Res 2002; 8:573 - 81; PMID: 11839679
   PubMed Web of Science ®Google Scholar
• Buick RN, Pullano R, Trent JM. Comparative properties of five human ovarian adenocarcinoma cell lines. Cancer Res 1985; 45:3668 - 76; PMID: 4016745
   PubMed Web of Science ®Google Scholar
• Yang H, He L, Kruk P, Nicosia SV, Cheng JQ. Aurora-A induces cell survival and chemoresistance by activation of Akt through a p53-dependent manner in ovarian cancer cells. Int J Cancer 2006; 119:2304 - 12; http://dx.doi.org/10.1002/ijc.22154; PMID: 16894566
   PubMed Web of Science ®Google Scholar
• Ruiz-Cortés ZT, Kimmins S, Monaco L, Burns KH, Sassone-Corsi P, Murphy BD. Estrogen mediates phosphorylation of histone H3 in ovarian follicle and mammary epithelial tumor cells via the mitotic kinase, Aurora B. Mol Endocrinol 2005; 19:2991 - 3000; http://dx.doi.org/10.1210/me.2004-0441; PMID: 16020485
   PubMed Web of Science ®Google Scholar
• Harrington EA, Bebbington D, Moore J, Rasmussen RK, Ajose-Adeogun AO, Nakayama T, et al. VX-680, a potent and selective small-molecule inhibitor of the Aurora kinases, suppresses tumor growth in vivo. Nat Med 2004; 10:262 - 7; http://dx.doi.org/10.1038/nm1003; PMID: 14981513
   PubMed Web of Science ®Google Scholar
• Lee EC, Frolov A, Li R, Ayala G, Greenberg NM. Targeting Aurora kinases for the treatment of prostate cancer. Cancer Res 2006; 66:4996 - 5002; http://dx.doi.org/10.1158/0008-5472.CAN-05-2796; PMID: 16707419
   PubMed Web of Science ®Google Scholar
• Gizatullin F, Yao Y, Kung V, Harding MW, Loda M, Shapiro GI. The Aurora kinase inhibitor VX-680 induces endoreduplication and apoptosis preferentially in cells with compromised p53-dependent postmitotic checkpoint function. Cancer Res 2006; 66:7668 - 77; http://dx.doi.org/10.1158/0008-5472.CAN-05-3353; PMID: 16885368
   PubMed Web of Science ®Google Scholar
• Anand S, Penrhyn-Lowe S, Venkitaraman AR. AURORA-A amplification overrides the mitotic spindle assembly checkpoint, inducing resistance to Taxol. Cancer Cell 2003; 3:51 - 62; http://dx.doi.org/10.1016/S1535-6108(02)00235-0; PMID: 12559175
   PubMed Web of Science ®Google Scholar
• Hata T, Furukawa T, Sunamura M, Egawa S, Motoi F, Ohmura N, et al. RNA interference targeting aurora kinase a suppresses tumor growth and enhances the taxane chemosensitivity in human pancreatic cancer cells. Cancer Res 2005; 65:2899 - 905; http://dx.doi.org/10.1158/0008-5472.CAN-04-3981; PMID: 15805292
   PubMed Web of Science ®Google Scholar
• Huang XF, Luo SK, Xu J, Li J, Xu DR, Wang LH, et al. Aurora kinase inhibitory VX-680 increases Bax/Bcl-2 ratio and induces apoptosis in Aurora-A-high acute myeloid leukemia. Blood 2007; PMID: 18160664
   PubMed Web of Science ®Google Scholar
• Tyler RK, Shpiro N, Marquez R, Eyers PA. VX-680 inhibits Aurora A and Aurora B kinase activity in human cells. Cell Cycle 2007; 6:2846 - 54; http://dx.doi.org/10.4161/cc.6.22.4940; PMID: 18032922
   PubMed Web of Science ®Google Scholar
• Ouchi M, Fujiuchi N, Sasai K, Katayama H, Minamishima YA, Ongusaha PP, et al. BRCA1 phosphorylation by Aurora-A in the regulation of G2 to M transition. J Biol Chem 2004; 279:19643 - 8; http://dx.doi.org/10.1074/jbc.M311780200; PMID: 14990569
   PubMed Web of Science ®Google Scholar